Suthin Songcharoen
Flowood, MSNPI 1255329371
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 539 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Amgen at 24.8% of the total. Reporting peaked in 2019 at $3,845 and has fallen 97.4% since, to $101 in 2024.
Across 539 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- UCB, Inc.$588
- Genentech USA, Inc.$485
- Johnson & Johnson$472
- E.r. Squibb & Sons, L.L.C.$434
- plus $3K from 16 others
Across 1 payment — averaging $17.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$17
What the payments were for
- Food & beverage$8,04499%
- Education$1071%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 121 | $2,023 |
| AbbVie | 98 | $1,531 |
| UCB, Inc. | 46 | $588 |
| Genentech USA, Inc. | 22 | $485 |
| Johnson & Johnson(2 entities) | 32 | $472 |
| E.r. Squibb & Sons, L.L.C. | 36 | $434 |
| Novartis | 30 | $420 |
| Pfizer | 46 | $403 |
| GSK | 24 | $370 |
| Lilly USA, LLC | 23 | $314 |
| Radius Health, Inc. | 17 | $203 |
| Regeneron Healthcare Solutions, Inc. | 12 | $197 |
| Mallinckrodt Hospital Products Inc. | 7 | $134 |
| Sanofi | 8 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $106 |
| Davol Inc. | 1 | $101 |
| Mallinckrodt Enterprises LLC | 6 | $94 |
| Boehringer Ingelheim | 5 | $75 |
| Acera Surgical, Inc. | 1 | $30 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $15 |
| Janssen Scientific Affairs, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$125
- ONPATTRO$106
- Phasix Mesh$101
- Enbrel$101
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.